1 this assay was investigated previously in a
multicenter study.
2 s an open-label, randomized, parallel-group,
multicenter study.
3 srael Deaconess Medical Center approved this
multicenter study.
4 n individual bone lesions from patients in a
multicenter study.
5 r 10 weeks in a double-blind, parallel-group
multicenter study.
6 dosis and its association with survival in a
multicenter study.
7 not previously been analyzed using a large,
multicenter study.
8 tion has not been validated in a prospective
multicenter study.
9 cm not amenable to RFA were included in this
multicenter study.
10 andomized, double-blind, placebo-controlled,
multicenter study.
11 itutional Review Board-approved, prospective
multicenter study.
12 results of a larger randomized, controlled,
multicenter study.
13 ients with CGD from 73 Turkish families in a
multicenter study.
14 fter allogeneic HCT within this prospective,
multicenter study.
15 Prospective,
multicenter study.
16 and 3 Months) is a prospective, single-arm,
multicenter study.
17 label, randomized, active-controlled, 3-arm,
multicenter study.
18 obtained at all sites for this prospective,
multicenter study.
19 international studies, and between single vs
multicenter studies.
20 o large multi-instrument, multimodality, and
multicenter studies.
21 ch as PSMA-617, which is also the subject of
multicenter studies.
22 ve studies, and there is a critical need for
multicenter studies.
23 nd harmonized image quality in (89)Zr-PET/CT
multicenter studies.
24 mage quality can be reached in (89)Zr PET/CT
multicenter studies.
25 e-blind, placebo-controlled, parallel group,
multicenter studies.
26 rt C (PN-3682-011 and -012) were open-label,
multicenter studies.
27 escriptive, cross-sectional, nonintervention
multicenter studies.
28 to 2013, 1,508 patients were recruited in a
multicenter study:
1,182 breast cancer, 262 melanoma, an
29 In this
multicenter study,
1182 patients hospitalized for CAP we
30 In a
multicenter study,
120 patients with ST-segment elevatio
31 In a prospective observational
multicenter study,
170 patients were investigated who co
32 In a prospective,
multicenter study,
198 eligible patients with diabetes w
33 this phase II, randomized placebo-controlled
multicenter study,
20 patients with active disease enrol
34 In this
multicenter study,
260 wide-field digital photographs of
35 In a prospective
multicenter study,
30 consecutive patients with severe d
36 In this
multicenter study,
3D myocardial perfusion CMR proved hi
37 andomized, double-blind, placebo-controlled,
multicenter study,
4 doses ZVHT or placebo were administ
38 In this prospective
multicenter study,
55 subjects with or at high risk for
39 In this
multicenter study,
a bundle comprising S. aureus screeni
40 The MR protocol implemented in this
multicenter study achieved highly reproducible measures
41 This
multicenter study addressed the course of disease for ea
42 In this phase IIIb, open-label,
multicenter study,
adult patients were trained to self-a
43 is German prospective, randomized controlled
multicenter study,
adult patients with moderate-to-sever
44 In an open-label,
multicenter study,
adults >/=65 years of age, vaccinated
45 This
multicenter study aims to assess long-term functional ou
46 In a prospective,
multicenter study among 106 pediatric kidney allograft r
47 Longitudinal,
multicenter study among birth cohorts in Menorca, Sabade
48 This
multicenter study analyzed Nocardia spp., including extr
49 This cross-sectional retrospective
multicenter study analyzed the clinical and genetic char
50 Comparisons to severe asthma
multicenter studies and available registries showed data
51 y of future research outputs, can facilitate
multicenter studies and meta-analyses of pooled data, an
52 prior mortality analyses from a more recent
multicenter study and a national data set was performed.
53 lerotic disease (ICAD) in a population-based
multicenter study and report examination and reader reli
54 sis, but the accuracy of this technique in a
multicenter study and the association of Tc 99m PYP myoc
55 ostic impact of CMR in an adequately powered
multicenter study and to evaluate the most potent CMR pr
56 e enrolled onto a prospective North American
multicenter study and were observed at least up to 12 mo
57 HIPAA-compliant institutional board approved
multicenter study,
and all participants provided written
58 (n = 992) were enrolled in this case-control
multicenter study,
and serum cytokine levels were measur
59 nition of PGD could be applied in a national
multicenter study,
and the cases it defined had more fre
60 However, large
multicenter studies are lacking.
61 Multicenter studies are necessary to validate these find
62 Prospective
multicenter studies are needed to evaluate these approac
63 Multicenter studies are needed to replicate these findin
64 Future
multicenter studies are needed to validate right-ventric
65 impact recruitment to the workforce; larger,
multicenter studies are needed to validate these results
66 Further
multicenter studies are needed using harmonized UFP meas
67 Prospective
multicenter studies are now needed to further validate t
68 f the design and results from 2 longitudinal
multicenter studies are presented.
69 -chronic liver failure (I-ACLF) derived from
multicenter studies are required in order to improve pro
70 Future prospective
multicenter studies are required to corroborate our find
71 This
multicenter study assembled genome-wide genotypic and ph
72 This prospective Australian
multicenter study assessed whether (68)Ga-PSMA PET/CT im
73 Data from
multicenter studies assessing programs designed to impro
74 used data from ACOSOG Z1071, a prospective,
multicenter study assessing sentinel lymph node surgery
75 ive, open-label, randomized, parallel-group,
multicenter study assessing the role of continuous warfa
76 In a prospective and
multicenter study,
children with suspected peanut or haz
77 This
multicenter study collected blood samples from children
78 ants: In an ongoing prospective, diagnostic,
multicenter study conducted at 9 emergency departments,
79 The SomoInsight Study was an observational,
multicenter study conducted between 2009 and 2011.
80 spective, population-based, cross-sectional,
multicenter study conducted between 2011 and 2013.
81 In this open label,
multicenter study conducted over 1-year follow-up, we ra
82 This
multicenter study confirms that SEE is a strong predicto
83 This
multicenter study confirms that the Working Formulation
84 This cross-sectional, academic
multicenter study consisted of 320 research volunteers (
85 tory computed tomography images from a large
multicenter study (
COPDGene) of current and former smoke
86 ine of 680 subjects participating in a large
multicenter study (
COPDGene) over approximately 5 years.
87 Using
multicenter study data in hospitalized decompensated inf
88 This prospective
multicenter study demonstrated that MIE is feasible and
89 This
multicenter study demonstrates that EVLP is associated w
90 This prospective,
multicenter study demonstrates that infection frequently
91 There are no large
multicenter studies describing the frequency and analges
92 ing account of potential confounders and the
multicenter study design.
93 Researchers in a recent
multicenter study developed and validated a novel progno
94 This
multicenter study enrolled 56 patients with DM and 51 co
95 This
multicenter study evaluated cefoxitin disk diffusion for
96 This
multicenter study evaluated the clinical performance cha
97 andomized, double-blind, placebo-controlled,
multicenter study evaluated the effects of intravenous h
98 This randomized, double-blind,
multicenter study evaluated the effects of tumor necrosi
99 This phase 2, open-label,
multicenter study evaluated the efficacy and safety of b
100 This semiprospective
multicenter study evaluated the LFD test for IPA diagnos
101 This is the first
multicenter study evaluating this treatment approach.
102 ghest validity and is recommended for use in
multicenter studies for rare diseases, such as pemphigus
103 isolates collected during the Global Enteric
Multicenter Study from seven study sites in Asia and Afr
104 The results of this large
multicenter study from the modern era suggest that SALV
105 The Global Enteric
Multicenter Study (
GEMS) investigated burden and etiolog
106 and hygiene access across the Global Enteric
Multicenter Study (
GEMS) sites in Africa and South Asia
107 We designed the Global Enteric
Multicenter Study (
GEMS) to identify the aetiology and p
108 ss causes of diarrhoea in the Global Enteric
Multicenter Study (
GEMS).
109 UFP) on health is still inconsistent and few
multicenter studies have been conducted so far especiall
110 gn, making generalization difficult, and few
multicenter studies have been conducted.
111 Numerous
multicenter studies have identified the factors determin
112 In this
multicenter study,
hypercapnia was associated with good
113 ary syndrome, but have not been validated in
multicenter studies in a cohort that allows comparisons.
114 (68)Ga-PSMA-11 is currently the subject of
multicenter studies in different countries.
115 contributed to by a growing number of other
multicenter studies in which imaging is embedded.
116 Conclusion In this prospective,
multicenter study in a selection of patients with ER-pos
117 16070 is an ongoing, single-arm, open-label,
multicenter study in antiretroviral therapy-naive, HIV-1
118 This is a prospective
multicenter study in children ages 3 months to 5 years w
119 Prospective
multicenter study in four intensive care units.
120 Prospective
multicenter study in Kenya from July 2012 through July 2
121 We performed a
multicenter study in order to clarify the present condit
122 retrospective, noninterventional, national,
multicenter study in patients from the Spanish Hepa-C re
123 pain scores compared with placebo in a large
multicenter study in patients with symptomatic knee oste
124 Using sera collected during a
multicenter study in patients with trauma, we found that
125 and Methods In a prospective, observational,
multicenter study in patients younger than 70 years old
126 ssays (ELISAs) in a prospective, controlled,
multicenter study in Peru, Venezuela, Cambodia, and the
127 The observational
multicenter study in the group of 456 HEN patients [142
128 This
multicenter study included 1,131 consecutive patients un
129 A retrospective, observational
multicenter study included 1252 patients with a complica
130 This prospective
multicenter study included 246 patients with a first ant
131 This
multicenter study included 34 unvaccinated patients with
132 This
multicenter study included 575 adult patients with TOF (
133 This
multicenter study included 911 patients from 3 LT center
134 This retrospective
multicenter study included patient data collected from J
135 This prospective
multicenter study included patients undergoing liver res
136 In a
multicenter study including 168 HCV patients receiving a
137 A retrospective
multicenter study including 18 HNF1B patients receiving
138 pproved this retrospective, HIPAA-compliant,
multicenter study;
informed consent was waived.
139 The analysis was also performed in a
multicenter study involving 107 patients with invasive a
140 ith [18F]-Florbetapir (INDIA-FBP) Study is a
multicenter study involving 18 AD evaluation units from
141 ory and degenerative neurologic disease in a
multicenter study involving 220 patients.
142 We conducted a
multicenter study involving consecutive patients with ci
143 In our phase 3, randomized, double-blind,
multicenter study involving patients with progressive th
144 A larger, prospective,
multicentered study is needed to validate these findings
145 easured sensitivity of MR biomarkers in this
multicenter study may be critically important to future
146 This
multicenter study measured PENK in 1,908 patients with a
147 2008 and 2012, a prospective, observational,
multicenter study (
MERCURY II) recruited 279 patients wi
148 Conclusions and Relevance: This
multicenter study noted significant differences in the q
149 An international,
multicenter study (
NTR 1310), the VICI-trial was perform
150 the design and interpretation of single- and
multicenter studies of patients with exercise-induced br
151 docarditis has occurred in all 3 prospective
multicenter studies of the Melody valve in North America
152 cancer, no prospective, quality-controlled,
multicenter studies of this strategy have been conducted
153 We conducted two phase 2, single-group,
multicenter studies of vemurafenib (at a dose of 960 mg
154 The present retrospective
multicenter study of (177)Lu-PSMA-617 RLT demonstrates f
155 This was a prospective observational
multicenter study of 100 mechanically ventilated patient
156 We conducted a
multicenter study of 101 patients with congenital dysfib
157 clinical outcome, we performed a prospective
multicenter study of 133 adult patients with primary MN
158 Prospective, controlled,
multicenter study of 154 patients with GA/AMD and 141 ag
159 We conducted a prospective
multicenter study of 172 living liver donors.
160 We conducted a prospective
multicenter study of 420 critically ill patients.
161 We performed a prospective
multicenter study of 48 patients with active CD and ulce
162 We performed an international
multicenter study of 514 patients who underwent resectio
163 This is a
multicenter study of 6 hydrophilic acrylic IOLs (Lentis
164 This
multicenter study of 8 EDs in the United States enrolled
165 escribe a well-designed and executed phase 3
multicenter study of a recombinant factor VIII (rFVIII)
166 A
multicenter study of adult patients with candidemia was
167 This was an observational
multicenter study of all consecutive adult patients diag
168 In this first
multicenter study of biomarker-determined cigarette smok
169 A retrospective
multicenter study of characteristics and outcomes of 318
170 This was a retrospective,
multicenter study of consecutive patients undergoing LAA
171 uation, and Education) registry to conduct a
multicenter study of consecutive patients who underwent
172 In a prospective
multicenter study of consecutive patients with suspected
173 COPDGene is a
multicenter study of current and former smokers that und
174 We analyzed data from a
multicenter study of endoscopic therapy to identify fact
175 Iron Overload Screening (HEIRS) Study was a
multicenter study of ethnically diverse participants tha
176 ients and Methods We performed a prospective
multicenter study of FDG-PET/CT scanning 12 weeks after
177 These observational data from this first
multicenter study of HCR suggest that there is no signif
178 We performed a
multicenter study of high-dose consolidation, without WB
179 (EPIC) study was a prospective observational
multicenter study of hospitalizations for community-acqu
180 e obtained from the IMAGEN Study, a European
multicenter study of impulsivity, reinforcement sensitiv
181 In a large
multicenter study of infants hospitalized with bronchiol
182 This was an open-label
multicenter study of iodine-124 ((124)I) -girentuximab P
183 Prospective observational
multicenter study of long-term neurodevelopmental effect
184 The MOMENTUM 3 trial (
Multicenter Study of MagLev Technology in Patients Under
185 , <1000 g) cases with IC and controls from a
multicenter study of neonatal candidiasis enrolled from
186 ting Stents) was a large-scale, prospective,
multicenter study of patients undergoing drug-eluting st
187 gn, Setting, and Participants: Retrospective
multicenter study of patients who underwent resection fo
188 In this prospective
multicenter study of post-operative patients with RVOT o
189 dolescents from the IMAGEN study (a European
multicenter study of reinforcement sensitivity in adoles
190 The second consisted of a
multicenter study of sequential antidepressant treatment
191 Data were collected by a large
multicenter study of sporadic retinoblastoma in which pa
192 A prospective
multicenter study of surface and intracortical depth ele
193 This was a retrospective,
multicenter study of the characteristics and outcomes of
194 We performed an open-label, prospective,
multicenter study of the effectiveness and tolerance of
195 We conducted a retrospective
multicenter study of the impact of baseline clinical fac
196 A
multicenter study of the investigational Virtuo system (
197 METHODS AND This is a retrospective,
multicenter study of the short- and intermediate-term ou
198 We performed a single-arm,
multicenter study of treatment-naive adults with HCV gen
199 We performed a prospective,
multicenter study of two-dimensional (2D) MRE in childre
200 This study analyzed data from ITAMY (ITalian
multicenter study on Acute MYocarditis) and evaluated CM
201 S undergoing isolated CABG from the European
Multicenter Study on Coronary Artery Bypass Grafting (E-
202 This is the first randomized, controlled
multicenter study on patient education in adult AD.
203 ed in 147 patients included in a prospective
multicenter study on the impact of tumor clearance evalu
204 In this
multicenter study,
one third of very elderly ICU patient
205 t significant differences between single and
multicenter studies,
or according to CVE adjudication av
206 In this large,
multicenter study,
patients who received cefazolin had a
207 In a
multicenter study,
patients with breast cancer who were
208 In this
multicenter study,
patients with confirmed genetic diagn
209 ouble-blind, randomized, placebo-controlled,
multicenter study,
patients with New York Heart Associat
210 In this
multicenter study,
patients with refractory large B-cell
211 This large
multicenter study provides evidence of an association be
212 This large
multicenter study provides strong evidence that SEAL adv
213 This
multicenter study randomized 189 patients (1 eye/patient
214 This prospective, controlled,
multicenter study randomized 440 patients to adjunctive
215 nd for articles identified as meta-analyses,
multicenter studies,
randomized controlled trials, and r
216 aphy-Negative Dense Breasts is a prospective
multicenter study recruiting asymptomatic women with mam
217 Further large
multicenter studies sharing the same imaging protocols a
218 Larger
multicenter studies should address the potential use of
219 This retrospective,
multicenter study showed that ribavirin as monotherapy m
220 Conclusion This
multicenter study shows that the diagnostic performance
221 This
multicenter study sought to determine whether difference
222 This
multicenter study sought to determine Z scores for commo
223 This
multicenter study sought to evaluate the accuracy of the
224 This
multicenter study sought to prospectively evaluate a dra
225 In this prospective,
multicenter study,
surgical inpatients from four German
226 This
multicenter study surveyed 21 US program directors in ge
227 Conclusions and Relevance: In this
multicenter study,
Tc 99m PYP cardiac imaging conferred
228 uble-blind, placebo-controlled international
multicenter study testing the effect of early IV beta-bl
229 idated ultrasound B-lines score (BL-US) in a
multicenter study that enrolled 392 hemodialysis patient
230 s was a phase III, randomized, double-blind,
multicenter study that evaluated the efficacy and safety
231 We performed a cross-sectional,
multicenter study that included 344 liver transplant rec
232 We performed a retrospective
multicenter study that involved 6 eye cancer centers fro
233 e Neuroimaging Initiative is a longitudinal,
multicenter study that is evaluating a range of biomarke
234 stration Cooperative Studies Program #468, a
multicenter study that randomized Parkinson's disease (P
235 In this large,
multicenter study,
the BD Max EBP assay showed superior
236 In this
multicenter study,
the BD Max xEBP showed a high correla
237 In our
multicenter study,
the incidence of germline mutations i
238 In this retrospective
multicenter study,
the presence of the BRAF V600E mutati
239 In this European
multicenter study,
the sensitivity and specificity of th
240 In this large, independently adjudicated,
multicenter study,
the stent fracture rate was low and n
241 In
multicenter studies,
tight glycemic control targeting a
242 e of breast cancer to NAC and support future
multicenter studies to test (18)F-FLT PET in a more unif
243 Prospective, large-scale
multicenter studies to validate the result are warranted
244 We present results from a blinded
multicenter study to address data portability across fou
245 We conducted a
multicenter study to address the prognosis of this condi
246 We conducted a
multicenter study to ascertain the diagnostic value of b
247 Multicenter study to assess safety/activity of ITX5061 i
248 We performed a
multicenter study to assess the outcomes and factors ass
249 e (RENAL-DES) was a prospective, randomized,
multicenter study to directly compare the efficacy in th
250 We performed a phase 3, placebo-controlled,
multicenter study to evaluate budesonide and mesalamine
251 We performed a prospective,
multicenter study to evaluate OCT findings in patients w
252 We conducted a prospective,
multicenter study to evaluate the performance of stool a
253 This
multicenter study,
to our knowledge, is the first phase
254 In a prospective
multicenter study,
two blinded raters independently exam
255 Multicenter studies using a common nutritional screening
256 findings merit the current efforts of large
multicenter studies using standardized sampling, shared
257 Cross-sectional
multicenter study using data from the Brazilian Metaboli
258 This
multicenter study validated single-center evidence that
259 This HIPAA-compliant prospective
multicenter study was approved by institutional review b
260 This HIPAA-compliant
multicenter study was approved by institutional review b
261 A retrospective
multicenter study was conducted (1992-2010) in tertiary
262 The
multicenter study was conducted from March 2011 through
263 This prospective, single-arm,
multicenter study was conducted from November 2012 to Ja
264 e, randomized, double-blind, parallel-group,
multicenter study was conducted in 5 Australian intensiv
265 A retrospective
multicenter study was conducted including dermatology de
266 A prospective
multicenter study was conducted to assess the immunogeni
267 A
multicenter study was conducted to evaluate the diagnost
268 A retrospective
multicenter study was conducted using the medical record
269 This
multicenter study was designed to (1) establish the refe
270 This retrospective
multicenter study was HIPAA compliant and approved by th
271 The
multicenter study was performed at tertiary care centers
272 An observational, longitudinal,
multicenter study was performed on patients with allergi
273 An observational, prospective,
multicenter study was performed.
274 A retrospective
multicenter study was performed.
275 The aim of this large
multicenter study was to assess the impact of salvage es
276 The aim of the EFFICAS I
multicenter study was to demonstrate the correlation bet
277 The aim of this
multicenter study was to describe clinical outcome after
278 The aim of this
multicenter study was to determine the genetic diversity
279 The aim of this single-arm, prospective,
multicenter study was to evaluate the performance and sa
280 The aim of this
multicenter study was to examine in a large cohort of pa
281 The aim of our prospective, community-based,
multicenter study was to reevaluate the liver disease pr
282 s in children enrolled in the Global Enteric
Multicenter Study was used to investigate the genomic di
283 In this uncontrolled, phase 1-2,
multicenter study,
we administered oral acalabrutinib to
284 In this
multicenter study,
we describe the characteristics and o
285 In this
multicenter study,
we examined the clinical utility of 7
286 is nonrandomized, parallel-cohort, phase 1b,
multicenter study,
we explored the safety and preliminar
287 In this
multicenter study,
we found that several machine learnin
288 In the present
multicenter study,
we have retrospectively examined diff
289 In this
multicenter study,
we implanted an active-fixation leadl
290 In this
multicenter study,
we included 37 patients with multiref
291 In an international, prospective,
multicenter study,
we quantified the incidence of incons
292 In a
multicenter study,
we randomized 200 patients with large
293 In a
multicenter study,
we randomized 200 patients with large
294 In a
multicenter study,
we randomly assigned adults requiring
295 In the present
multicenter study,
we used structural magnetic resonance
296 inclusion criteria and endpoints leading to
multicenter studies,
will hopefully lead to advancements
297 ethics committee approved this retrospective
multicenter study with a waiver of informed consent.
298 isk and suggest that further validation in a
multicenter study with larger cohorts may eventually adv
299 Within this setting of a prospective,
multicenter study with uniform GVHD prophylaxis, conditi
300 In a prospective
multicenter study without controls, a transcatheter pace